我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Development of high resistant starch wheat that reduces glycemic (GI) index, chance of Type II diabetes and tumorigenesis and improve blood glucose level and microbiome.

Vibhu Kumar

Conventional wheat-based foods contain high concentration of highly digestible starches that give high glycemic index (GI). It might contribute to metabolic disorder such as type II diabetes, colon cancer and cardiovascular disease. The main objective of this study was to determine the effect of high resistant starch (HRS, ~40%) on the postprandial glycemic value in contrast to food made from conventional wheat containing low resistant starch (LRS, ~1%). Further, HRS wheat was explored to study the ameliorative effects of RS on type II diabetes and tumorigenesis. Both In-vitro and In-vivo study were designed for GI study of HRS wheat mutant. Six groups of C57BL6/J mice were included for GI study. Among 5 HRS wheat mutant with control ‘C306’ (LRS), two mutant ‘TAC 28’ and ‘TAC 35’ were found significantly low GI (~25-30% lower GI than ‘C306’) that were confirmed by Invivo. Blood glucose level (BGL) and body weight of HRS line fed mice was lower than LRS line fed mice.